کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2863119 | 1573125 | 2016 | 6 صفحه PDF | دانلود رایگان |
BackgroundDevice thrombosis remains a complication of long-term mechanical circulatory support with HeartMate II.Materials and MethodsRetrospective analysis of patients who underwent destination therapy (DT) with HeartMate II from January 2010-December 2013 at Tulane University Medical Center.ResultsEighteen HeartMate II were implanted for DT. Survival rates were 72.2% at 1 year and 37% at 2 years. Device thrombosis in 7 of the 18 patients (39%) accounted for the low survival rate at 2 years. Known risk factors for device thrombosis were equally present in patients with and without device thrombosis. In contrast to patients without device thrombosis, all patients with device thrombosis had a pre-existing systemic inflammatory condition.ConclusionsPatients with pre-existing systemic inflammatory conditions are at risk of device thrombosis during DT.
Journal: The American Journal of the Medical Sciences - Volume 351, Issue 5, May 2016, Pages 441–446